Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, dal 1982 In collaborazione con l'Associazione Culturale Pediatri

Caso contributivo

PDF MeBrain

Eccesso di iodio da mezzo di contrasto in gravidanza: esiste un rischio reale per la funzionalità tiroidea del neonato?

Exess of iodine by contrast media during pregnancy: is there a real risk for the nnewborn's thyroid function?

Angelo Tropeano1, Daniele Rapino2, Dinara Guseinova2, Luca Sabino1, Diletta Martino3, Emilio Palumbo2
1SC Pediatria, ASST Grande Ospedale Metropolitano Niguarda, Milano
2SC Pediatria e Neonatologia, ASST Valtellina e Alto Lario, Ospedale Civile di Sondrio
3SC Neonatologia e terapia intensiva neonatale, ASST Grande Ospedale Metropolitano Niguarda, Milano

Aprile 2026 | DOI: 10.53126/MEBXXIXA093

Abstract
The case report provides some interesting insights into the management of newborns exposed to iodine-based contrast media during pregnancy. The analysis of recent scientific literature has clarified the actual neonatal risks but has left some questions unanswered and opened the way for future researches.
Riassunto
Il caso clinico proposto fornisce spunti interessanti sulla gestione del neonato esposto a mezzo di contrasto iodato durante la gravidanza. L’analisi della Letteratura scientifica chiarisce i rischi reali per il neonato, ma lascia irrisolte alcune questioni aprendo a futuri campi di ricerca.
Contenuto riservato

Per leggere l'articolo è necessario effettuare il login.

Per l'acquisto del singolo articolo scrivi a abbonamenti@medicoebambino.com (la mail si prepara da sola con gli estremi dell'articolo); se accedi, la richiesta parte con un click.

Bibliografia

  1. Tremblay E, Thérasse E, Thomassin-Naggara I, Trop I. Quality initiatives: guidelines for use of medical imaging during pregnancy and lactation. Radiographics 2012;32(3):897-911. DOI: 10.1148/rg.323115120.
  2. Lee SY, Rhee CM, Leung AM, Braverman LE, Brent GA, Pearce EN. A review: Radiographic iodinated contrast media-induced thyroid dysfunction. J Clin Endocrinol Metab 2015;100(2):376-83. DOI: 10.1210/jc.2014-3292.
  3. Atwell TD, Lteif AN, Brown DL, McCann M, Townsend JE, Leroy AJ. Neonatal thyroid function after administration of IV iodinated contrast agent to 21 pregnant patients. AJR Am J Roentgenol 2008;191(1):268-71. DOI: 10.2214/AJR.07.3336.
  4. Webb JA, Thomsen HS, Morcos SK; Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol 2005;15(6):1234-40. DOI: 10.1007/s00330-004-2583-y.
  5. Stubbe P, Heidemann P, Schörnbrand P, Ulbrich R. Transient congenital hypothyroidism after amniofetography. Eur J Pediatr 1980;135(1):97-9. DOI: 10.1007/BF00445902.
  6. Rodesch F, Camus M, Ermans AM, Dodion J, Delange F. Adverse effect of amniofetography on fetal thyroid function. Am J Obstet Gynecol 1976;126(6):723-6. DOI: 10.1016/0002-9378(76)90528-7.
  7. van Welie N, Portela M, Dreyer K, et al. Iodine contrast prior to or during pregnancy and neonatal thyroid function: a systematic review. Eur J Endocrinol 2021;184(1):189-98. DOI: 10.1530/EJE-20-0627.
  8. Righini M, Robert-Ebadi H, Cremonesi A, et al; CT-PE-Pregnancy group. Risk of neonatal hypothyroidism in newborns from mothers exposed to CTPA during pregnancy: Ancillary data from a prospective outcome study. J Thromb Haemost 2022;20(11):2550-5. DOI: 10.1111/jth.15843.
  9. Bednarczuk T, Brix TH, Schima W, Zettinig G, Kahaly GJ. 2021 European Thyroid Association Guidelines for the Management of Iodine-Based Contrast Media-Induced Thyroid Dysfunction. Eur Thyroid J 2021;10(4):269-84. DOI: 10.1159/000517175.
  10. Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid 2017;27(3):315-89. DOI: 10.1089/thy.2016.0457. Erratum in: Thyroid 2017;27(9):1212. DOI: 10.1089/thy.2016.0457.correx.
  11. van Welie N, Roest I, Portela M, et al; H2Oil Study Group. Thyroid function in neonates conceived after hysterosalpingography with iodinated contrast. Hum Reprod 2020;35(5):1159-67. DOI: 10.1093/humrep/deaa049.
  12. Patel J, Landers K, Li H, Mortimer RH, Richard K. Delivery of maternal thyroid hormones to the fetus. Trends Endocrinol Metab 2011;22(5):164-70. DOI: 10.1016/j.tem.2011.02.002.
  13. Kaneshige T, Arata N, Harada S, et al. Changes in serum iodine concentration, urinary iodine excretion and thyroid function after hysterosalpingography using an oil-soluble iodinated contrast medium (lipiodol). J Clin Endocrinol Metab 2015;100(3):E469-72. DOI: 10.1210/jc.2014-2731.
  14. Callahan MJ, Iyer RS, Wassner AJ. Is Thyroid Monitoring Warranted in Infants and Young Children After Intravascular Administration of Iodine-Based Contrast Media? AJR Am J Roentgenol 2023;220(1):144-5. DOI: 10.2214/AJR.22.28007.
  15. U.S. Food and Drug Administration. FDA recommends thyroid monitoring in babies and young children who receive injections of iodine-containing contrast media for medical imaging. Children with underlying conditions and newborns at higher risk. Updated 26 April 2023.
  16. Roti E. Regulation of thyroid-stimulating hormone (TSH) secretion in the fetus and neonate. J Endocrinol Invest 1988;11(2):145-58. DOI: 10.1007/BF03350124.